← Open Payments lookup

MICHAEL DOWNING: Open Payments

NPI 1639159346 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$847 in 37 payments from 7 companies in 2025. Trend: 2023 $627 · 2024 $648 · 2025 $847

Food & beverage: $847
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc10$253
Otsuka America Pharmaceutical, Inc.8$197
E.R. Squibb & Sons, L.L.C.8$137
Teva Pharmaceuticals USA, Inc.3$91
ABBVIE INC.4$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Alkermes, Inc.2$37

Products named: INVEGA SUSTENNA, REXULTI, COBENFY, UZEDY, VRAYLAR, CAPLYTA, ARISTADA.

Industry payments across TX — which companies pay providers there.